National Drug Abuse Treatment 

black line
White Sep

Use your browser's back button to choose another title or click here for a New Search.

How to Get the Poster

 Open PDF


Bookmark and Share

The Clinical Trials Network and Treatment Innovations: Differences in Counselor Attitudes toward Buprenorphine.

Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, June 17-22, 2006.

Hannah K. Knudsen, PhD, Lori J. Ducharme, PhD, Paul M. Roman, PhD, J. Aaron Johnson, PhD (University of Georgia).

A critical research question in the CTN is whether involvement in the CTN has implications for the attitudes of clinicians toward innovative practices. One such innovation is buprenorphine, a medication approved for the treatment of opiate dependence and the subject of multiple CTN protocols (including CTN-0001, CTN-0002, and CTN-0010). This study uses data collected as part of the National Treatment Center Study, which includes a component that uses the CTN as a platform for health services research. It compared CTN counselors and non-CTN counselors on their perceptions of the acceptability of buprenorphine, finding that CTN counselors are more receptive towards the medication than counselors outside the CTN. This difference appears to be due to the greater training and implementation of buprenorphine in CTN-affiliated centers, suggesting that training and implementation of novel treatment techniques are strongly associated with counselors' attitudes towards these innovations. (Poster, PowerPoint slides, English, 2006)

Keywords: Attitudes of health personnel | Buprenorphine | Community health services | CTN platform/ancillary study | Health services research | National Treatment Center Study (NTCS) | Pharmacological therapy | College on Problems of Drug Dependence (CPDD) annual meeting 2006

Document No: 133

Submitted by Hannah Knudsen, PhD, University of Georgia, 6/22/2006.

Ducharme, Lori J. search
Johnson, J. Aaron search
Knudsen, Hannah K. search mail
Roman, Paul M. search

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 4/2009 --